Guardant Health (GH) is scheduled to report first-quarter 2024 results on May 9, after market close. In the last reported quarter, the company’s earnings missed expectations by 69.89%. Factors to Consider The Zacks Consensus Estimate for Guardant’s total revenues is pegged at around $151 million, while the same for earnings is pegged at a loss of 72 cents per share. Both metrics indicate improvements over the year-ago quarter’s levels. Through its screening business, Guardant intends to provide critical ins ...